Pfizer faces some major LoE headwinds, but the stock is cheap and offers a large dividend, offering a solid total return potential. Click to read more on PFE.

Vaxcyte stock catapulted Monday after its experimental pneumococcal vaccine proved it's not inferior to marketed shots from ...

The labels were allegedly applied to vials containing cheaper medicines and used to make them appear to be genuine Pfizer products.

NVO and PFE offer different growth paths, with diversified portfolios, pipelines and near-term challenges shaping their ...

Detailed results are competitive with Dupixent and Ebglyss, but the drug lacks differentiation amid an increasingly ...

VIENNA — More than half of all patients with moderate-to-severe atopic dermatitis of the hands and feet treated with lebrikizumab (Ebglyss) monotherapy in a phase 3b trial achieved the primary ...

Acquisition adds specialist injection moulding expertise, an experienced team and a strong platform for further growth ...

Michael Mina, MD, PhD, explains LIBERTY trial findings on VYD2311 tolerability alone and given with an mRNA COVID-19 vaccine.

Study met primary endpoint, showing a statistically significant increase in the percentage of participants achieving EASI-75 versus placebo at Week 16, for the potentially first-in-class trispecific ...

Health authorities often advise people to get their flu vaccine by the end of October – but as an epidemiologist focusing on ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Subscribe to our WhatsApp Channel Many Sri Lankans took the Pfizer-BioNTech vaccine during the pandemic, so a post claiming ...